| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.33B | +12.1% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.02B | +27.0% |
| Gross margin | 28.9% | Net margin 6.8% |
| Revenue Q/Q | +18.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.23B | 71.1% |
| R&D | ¥0.02B | 5.4% |
| SG&A | ¥0.04B | 11.7% |
| Tax & other | ¥0.00B | 1.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
恒实科技 ・ 友讯达 ・ 三德科技 ・ 久之洋 ・ 海波重科 ・ 新迅达 ・ 新光药业 ・ 科大国创 ・ 爱司凯 ・ 世名科技 ・ 辰安科技 ・ 博思软件
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies